286 related articles for article (PubMed ID: 22324445)
1. AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney.
Lempiäinen J; Finckenberg P; Levijoki J; Mervaala E
Br J Pharmacol; 2012 Jul; 166(6):1905-15. PubMed ID: 22324445
[TBL] [Abstract][Full Text] [Related]
2. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo.
Lieberthal W; Tang M; Lusco M; Abate M; Levine JS
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F731-F739. PubMed ID: 27252492
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
5. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
6. AICAR attenuates organ injury and inflammatory response after intestinal ischemia and reperfusion.
Idrovo JP; Yang WL; Jacob A; Aziz M; Nicastro J; Coppa GF; Wang P
Mol Med; 2015 Mar; 20(1):676-83. PubMed ID: 25611433
[TBL] [Abstract][Full Text] [Related]
7. Activation of insulin signaling and energy sensing network by AICAR, an AMPK activator in insulin resistant rat tissues.
Radika MK; Anuradha CV
J Basic Clin Physiol Pharmacol; 2015 Nov; 26(6):563-74. PubMed ID: 26124049
[TBL] [Abstract][Full Text] [Related]
8. Whether AICAR in Pregnancy or Lactation Prevents Hypertension Programmed by High Saturated Fat Diet: A Pilot Study.
Tsai WL; Hsu CN; Tain YL
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32053935
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 2 protects against renal ischaemia/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling.
Tan XH; Zheng XM; Yu LX; He J; Zhu HM; Ge XP; Ren XL; Ye FQ; Bellusci S; Xiao J; Li XK; Zhang JS
J Cell Mol Med; 2017 Nov; 21(11):2909-2925. PubMed ID: 28544332
[TBL] [Abstract][Full Text] [Related]
10. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
11. Caloric restriction ameliorates kidney ischaemia/reperfusion injury through PGC-1α-eNOS pathway and enhanced autophagy.
Lempiäinen J; Finckenberg P; Mervaala EE; Sankari S; Levijoki J; Mervaala EM
Acta Physiol (Oxf); 2013 Aug; 208(4):410-21. PubMed ID: 23710679
[TBL] [Abstract][Full Text] [Related]
12. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
13. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.
Sun Y; Li J; Xiao N; Wang M; Kou J; Qi L; Huang F; Liu B; Liu K
Pharmacol Res; 2014 Nov; 89():19-28. PubMed ID: 25108154
[TBL] [Abstract][Full Text] [Related]
15. Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction.
Paiva MA; Gonçalves LM; Providência LA; Davidson SM; Yellon DM; Mocanu MM
Cardiovasc Drugs Ther; 2010 Feb; 24(1):25-32. PubMed ID: 20229055
[TBL] [Abstract][Full Text] [Related]
16. κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation.
Zhang S; Zhou Y; Zhao L; Tian X; Jia M; Gu X; Feng N; An R; Yang L; Zheng G; Li J; Guo H; Fan R; Pei J
Eur J Pharmacol; 2018 Aug; 833():100-108. PubMed ID: 29856969
[TBL] [Abstract][Full Text] [Related]
17. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
19. The AMPK Activator Aicar Ameliorates Age-Dependent Myocardial Injury in Murine Hemorrhagic Shock.
Matsiukevich D; Piraino G; Klingbeil LR; Hake PW; Wolfe V; O'Connor M; Zingarelli B
Shock; 2017 Jan; 47(1):70-78. PubMed ID: 27513082
[TBL] [Abstract][Full Text] [Related]
20. AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.
Banek CT; Bauer AJ; Needham KM; Dreyer HC; Gilbert JS
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1159-65. PubMed ID: 23417865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]